Overview
Status
Active
Registry date
2012-04-27
Share capital
5 000,00 PLN
Activity description
Bioveta Polska produces veterinary medicinal products. Its range includes carbetocin injection solution for cattle and pigs, and BioBos BTV 3 suspension for sheep and cattle.
Financials
Revenue history (in k)
Filing timeliness
5 of 6 financial statements were filed late (the longest delay 347 days for 2021).
- 202512/08/2026
- 202414/08/2025
- 202315/08/2024
- 202228/06/2023
- 202127/06/2023
- 202016/03/2022
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 28.79kMedianUSD 112.93kAverageUSD 1.39m
Net profit
This companyUSD -4.35kMedianUSD 3.36kAverageUSD 117.95k
Operating costs
This companyUSD 33.10kMedianUSD 100.06kAverageUSD 1.26m
Assets
This companyUSD 34.34kMedianUSD 92.09kAverageUSD 1.28m
Industry
Offer
- Veterinary medicines
- Animal vaccines
- Veterinary preparations
Authorized Representatives
Marek Vystavel – Management Board Member
Manner of representation
Each member of the management board independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Bioveta Holdings A.s. | 100 | $1,350.62 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2012-05-16.
84 1050 1214 1000 0090 3268 7775- 40 1050 1214 1000 0090 3268 7791
- 62 1050 1214 1000 0090 3268 7783
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Sep 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $3,639$3,639 | Prezes Zakładu Ubezpieczeń Społecznych | |
| Sep 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $2,708$2,708 | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $3,393$3,393 | Prezes Zakładu Ubezpieczeń Społecznych |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Sacada Pracownia Badawczo-Projektowasp. z o.o. | $50,099.97 | sacada.pl | ||
| Think Poland Servicessp. z o.o. | $48,738.36 | thinkpoland.org | ||
| Premium Choice Research & Consultingsp. z o.o. | $39,295.79 | premium-choice-research.com | ||
| Elektro Artsp. z o.o. | $35,799.36 | elektro-art.net | ||
| Expertdatasp. z o.o. | $30,480.12 | expertdata.pl | ||
| Retail Labsp. z o.o. | $28,620.97 | retaillab.pl | ||
| Centrum Badań Rynkowych i Społecznychsp. z o.o. | $16,406.48 | cebris.pl | ||
| Daxen Itsp. z o.o. + limited partnership | $15,980.18 | daxenit.pl | ||
| Polska Izba BiznesuChamber of commerce | $15,547.31 | polskaizbabiznesu.pl | ||
| Game Time Projectsp. z o.o. | $14,700.69 | reqiu.eu |
Change history
| Date | Event | |
|---|---|---|
| 2021-01-07 | Address change (Ul. Prosta 51, 00-838, Warszawa → Ul. Chorzowska 150, 40-101, Katowice) | |
| 2016-03-31 | Address change (Erazma Ciołka 11a/102a, 01-445, Warszawa → Ul. Prosta 51, 00-838, Warszawa) | |
| 2016-03-14 | PKD change (Removed: 01, 02, 03, 05, 06, 07, 08, 09, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 35, 36, 37, 38, 39, 41, 42, 43, 45, 46, 47, 49, 50, 51, 52, 53.2, 55, 56, 58, 59, 60, 61, 62, 63, 64.19.Z, 64.2, 64.9, 66.19, 66.2, 68, 70, 71, 72, 73, 74, 77, 78, 79.9, 81, 82, 85.5, 85.6, 86.2, 86.9, 90, 91, 92, 93, 95, 96; Added: 21.10.Z, 21.20.Z, 46.46.Z, 52.10.B, 58.14.Z, 63.99.Z, 73.20.Z, 85.60.Z, 96.09.Z) | |
| 2014-01-31 | Address change (Al. Jana Pawła Ii 27, 00-867, Warszawa → Erazma Ciołka 11a/102a, 01-445, Warszawa) | |
| 2012-04-27 | Entered in the register |
FAQ
Last updated: 2026-10-07